Agency
Manet Community Health Center, INC.
Manet Community Health Center, INC. was paid $21.82M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 92% of everything it billed.
33Billing provider infoMANET COMMUNITY HEALTH CENTER, INC.
NORTH QUINCY, MA 02171
NORTH QUINCY, MA 02171
33aNPI1114027539assigned 09/25/2006
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$21.82M
24GClaims331,312
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Massachusetts
Rank by total paid#31 of 169
Median peer was paid$1.37M
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,697 | $2.98M | |
| 2019 | 46,579 | $3.53M | |
| 2020 | 47,223 | $3.57M | |
| 2021 | 48,441 | $3.65M | |
| 2022 | 51,305 | $5.33M | |
| 2023 | 49,441 | $1.98M | |
| 2024incomplete | 45,626 | $784K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 92% | 146,310 | 127,934 | $19.98M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 14,156 | 13,881 | $227K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 74,316 | 68,616 | $158K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 872 | 870 | $129K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,341 | 2,331 | $126K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 737 | 735 | $121K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,277 | 2,032 | $110K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 35,072 | 33,146 | $106K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,025 | 1,021 | $99K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 679 | 678 | $93K |
| 90686 | <1% | 5,624 | 5,307 | $81K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 392 | 392 | $54K |
68 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 525 | $48K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,967 | $44K |
| 99050 | <1% | 815 | $42K | |
| G0467 | Community health center visit, returning patient | <1% | 2,411 | $40K |
| 97802 | <1% | 367 | $37K | |
| 92015 | Determination of refractive state | <1% | 2,828 | $37K |
| 97803 | <1% | 519 | $34K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,960 | $32K |
| 0001A | <1% | 635 | $26K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 374 | $26K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,042 | $24K |
| 0002A | <1% | 411 | $19K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 408 | $12K |
| 0012A | <1% | 244 | $12K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 825 | $10K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18,381 | $10K |
| 0011A | <1% | 276 | $10K | |
| 90715 | <1% | 340 | $10K | |
| 90746 | <1% | 160 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,054 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 635 | $8K |
| 99173 | <1% | 528 | $5K | |
| 99383 | <1% | 43 | $4K | |
| 99000 | <1% | 3,880 | $4K | |
| 90480 | <1% | 169 | $3K | |
| 91320 | <1% | 25 | $3K | |
| 92551 | <1% | 209 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 18 | $2K |
| 81003 | <1% | 620 | $1K | |
| 0031A | <1% | 25 | $1K | |
| 90716 | <1% | 98 | $1K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 33 | $997.92 |
| 99382 | <1% | 14 | $888.00 | |
| 93000 | <1% | 58 | $744.38 | |
| 99384 | <1% | 12 | $666.00 | |
| 99188 | <1% | 27 | $642.60 | |
| 81025 | <1% | 86 | $529.07 | |
| 96127 | <1% | 34 | $296.82 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $221.02 |
| 90651 | <1% | 39 | $208.84 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17 | $184.86 |
| 91322 | <1% | 47 | $145.92 | |
| G0008 | Administration of influenza virus vaccine | <1% | 209 | $124.66 |
| 90707 | <1% | 41 | $85.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,176 | $63.43 |
| 0124A | <1% | 18 | $45.87 | |
| 90662 | <1% | 67 | $43.95 | |
| 0054A | <1% | 12 | $40.00 | |
| 81002 | <1% | 13 | $31.32 | |
| 90656 | <1% | 220 | $30.11 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 106 | $29.23 |
| 90474 | <1% | 14 | $9.84 | |
| 90697 | 0% | 117 | $0.00 | |
| 90677 | 0% | 184 | $0.00 | |
| 0064A | 0% | 24 | $0.00 | |
| 90744 | 0% | 42 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 45 | $0.00 |
| 36416 | 0% | 14 | $0.00 | |
| 1111F | 0% | 42 | $0.00 | |
| 90723 | 0% | 13 | $0.00 | |
| 0134A | 0% | 24 | $0.00 | |
| 90633 | 0% | 261 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 532 | $0.00 |
| 90670 | 0% | 46 | $0.00 | |
| 90648 | 0% | 47 | $0.00 | |
| 90681 | 0% | 17 | $0.00 | |
| 90713 | 0% | 27 | $0.00 | |
| J2315 | Injection, naltrexone, depot form, 1 mg | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIERRA, CYNTHIA (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Manet Community Health Center, INC. | North Quincy, MA | $2.83M |
| Manet Community Health Center, INC. | Taunton, MA | $1.59M |
| Manet Community Health Center, INC. | Quincy, MA | $477K |
| Manet Community Health Center, INC. | Hull, MA | $293K |
| Manet Community Health Center, INC. | Quincy, MA | $201K |
| Manet Community Health Center, INC. | Attleboro, MA | $191K |
| Manet Community Health Center, INC. | Quincy, MA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.